Ami Organics Ltd
NSE:AMIORG

Watchlist Manager
Ami Organics Ltd Logo
Ami Organics Ltd
NSE:AMIORG
Watchlist
Price: 2 299.35 INR 7.6% Market Closed
Market Cap: 94.1B INR
Have any thoughts about
Ami Organics Ltd?
Write Note

Ami Organics Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ami Organics Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Ami Organics Ltd
NSE:AMIORG
Depreciation & Amortization
â‚ą160.6m
CAGR 3-Years
57%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Depreciation & Amortization
â‚ą15.2B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
â‚ą10.4B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
â‚ą25.5B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
â‚ą8.1B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Depreciation & Amortization
â‚ą4B
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ami Organics Ltd
Glance View

Market Cap
94.1B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
1 495.1 INR
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Ami Organics Ltd's Depreciation & Amortization?
Depreciation & Amortization
160.6m INR

Based on the financial report for Mar 31, 2024, Ami Organics Ltd's Depreciation & Amortization amounts to 160.6m INR.

What is Ami Organics Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
44%

Over the last year, the Depreciation & Amortization growth was 30%. The average annual Depreciation & Amortization growth rates for Ami Organics Ltd have been 57% over the past three years , 44% over the past five years .

Back to Top